- Filed
- May 29, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2020 · May 22, 2020 | 6.57M sh |
| Shares Diluted | Q2 2020 · Mar 31, 2020 | 6.57M sh |
| Shares Diluted | Q2 2020 · Mar 31, 2020 | 6.65M sh |
| Shares Diluted | Q2 2020 · Mar 31, 2019 | 6.69M sh |
| Shares Diluted | Q2 2020 · Mar 31, 2019 | 6.69M sh |
| Operating Cash Flow | Q2 2020 · Mar 31, 2020 | $1.55M |
| Operating Cash Flow | Q2 2020 · Mar 31, 2019 | −$924K |
| Cash And Equivalents | Q2 2020 · Mar 31, 2020 | $8.98M |
| Cash And Equivalents | Q2 2020 · Sep 30, 2019 | $4.31M |
| Total Liabilities | Q2 2020 · Mar 31, 2020 | $2.35M |
| Total Liabilities | Q2 2020 · Sep 30, 2019 | $1.78M |
| Total Assets | Q2 2020 · Mar 31, 2020 | $92.37M |
| Total Assets | Q2 2020 · Sep 30, 2019 | $90.69M |
| Total Assets restated | Q2 2020 · Mar 31, 2019 | $89.1M |
| Eps Diluted | Q2 2020 · Mar 31, 2020 | −$0.01 |
| Eps Diluted | Q2 2020 · Mar 31, 2020 | $0.15 |
| Eps Diluted | Q2 2020 · Sep 30, 2019 | $1.04 |
| Eps Diluted | Q2 2020 · Mar 31, 2019 | $0.27 |
| Eps Diluted | Q2 2020 · Mar 31, 2019 | $0.46 |
| Eps Basic | Q2 2020 · Mar 31, 2020 | −$0.01 |
| Eps Basic | Q2 2020 · Mar 31, 2020 | $0.15 |
| Eps Basic | Q2 2020 · Sep 30, 2019 | $1.04 |
| Eps Basic | Q2 2020 · Mar 31, 2019 | $0.27 |
| Eps Basic | Q2 2020 · Mar 31, 2019 | $0.46 |
| Sga Expense | Q2 2020 · Mar 31, 2020 | $3.91M |
| Sga Expense | Q2 2020 · Mar 31, 2020 | $7.1M |
| Sga Expense | Q2 2020 · Sep 30, 2019 | $13.43M |
| Sga Expense | Q2 2020 · Mar 31, 2019 | $3.4M |
| Sga Expense | Q2 2020 · Mar 31, 2019 | $7.32M |
| Revenue | Q2 2020 · Mar 31, 2020 | $4.05M |
| Revenue | Q2 2020 · Mar 31, 2020 | $8.71M |
| Revenue | Q2 2020 · Mar 31, 2019 | $5.86M |
| Revenue | Q2 2020 · Mar 31, 2019 | $11.56M |
| Stockholders Equity | Q2 2020 · Sep 30, 2019 | $88.9M |
| Capex | Q2 2020 · Mar 31, 2019 | $112K |